United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025
SKU ID :DPI-14816318 | Published Date: 24-Jun-2019 | No. of pages: 95Description
TOC
1. Executive Summary
2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
3. United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
4. United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
5. United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
5.1 United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
5.2 United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
6.1 Market Drivers
6.2 Market Inhibitors
7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
7.1 Prevnar / Prevnar 13
7.2 Pneumovax 23
7.3 Menactra
7.4 Bexsero
7.5 Menveo
7.6 Trumenba
8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System
9.1 Reimbursement Policies
9.2 Regulation System
10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
11. Major Deals in the Vaccines Market
11.1 Merger & Acquisitions
11.2 Collaboration Deals
11.3 Licensing Agreement
11.4 Exclusive Agreement
11.5 Distribution Agreement
11.6 Partnerships
12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development
12.3 Merck
12.3.1 Business Overview
12.3.2 Vaccines Portfolio
12.3.3 Recent Development
12.4 Pfizer
12.4.1 Business Overview
12.4.2 Vaccines Portfolio
12.4.3 Recent Development
Tables & Figures
List of Tables
Table 5–1: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–2: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–3: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2015 – 2018
Table 5–4: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–5: United States Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–6: United States Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 8–1: United States Pneumococcal & Meningococcal Adult Vaccines Price, 2019 – 2020
Table 8–2: United States Pneumococcal & Meningococcal Pediatric Vaccines Price, 2019 – 2020
Table 9–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 11–1: Merger & Acquisitions in the Vaccines Market
Table 11–2: Collaboration Deal in the Vaccines Market
Table 11–3: Licensing Agreement in the Vaccines Market
Table 11–4: Exclusive Agreement in the Vaccines Market
Table 11–5: Distribution Agreement in the Vaccines Market
Table 6–6: Partnerships in the Vaccines Market
List of Figures
Figure 2–1: United States Pneumococcal & Meningococcal Vaccines Market Size(Million US$),2015 – 2018
Figure 2–2: United States Pneumococcal & Meningococcal Vaccines Market Size Forecast(Million US$),2019 – 2025
Figure 3–1: United States Pneumococcal Vaccines Market Size (Million US$),2015 – 2018
Figure 3–2: United States Pneumococcal Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 4–1: United States Meningococcal Vaccines Market Size (Million US$),2015 – 2018
Figure 4–2: United States Meningococcal Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 7–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2018
Figure 7–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025
Figure 7–3: United States Pneumovax 23 Market Value (Million US$),2015 – 2018
Figure 7–4: United States Pneumovax 23 Market Value Forecast (Million US$),2019 – 2025
Figure 7–5: United States Menactra Market Value (Million US$),2015 – 2018
Figure 7–6: United States Menactra Market Value Forecast (Million US$),2019 – 2025
Figure 7–7: United States Bexsero Market Value (Million US$),2015 – 2018
Figure 7–8: United States Bexsero Market Value Forecast (Million US$),2019 – 2025
Figure 7–9: United States Menveo Market Value (Million US$),2015 – 2018
Figure 7–10: United States Menveo Market Value Forecast (Million US$),2019 – 2025
Figure 7–11: United States Trumenba Market Value (Million US$),2017 – 2018
Figure 7–12: United States Trumenba Market Value Forecast (Million US$),2019 – 2025
Companies
- PRICE
-
$1050$1650Buy Now